Natural course of low risk neuroblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Natural course of low risk neuroblastoma

Published:2011-09-15 Issue:5 Volume:58 Page:690-694
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Shuangshoti Somruetai,Shuangshoti Shanop,Nuchprayoon Issarang,Kanjanapongkul Somjai,Marrano Paula,Irwin Meredith S.,Thorner Paul S.

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference36 articles.

1. Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: A Children's Cancer Group study;Perez;J Clin Oncol,2000

2. Neuroblastoma;Maris;Lancet,2007

3. Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group;London;J Clin Oncol,2005

4. Screening for neuroblastoma: Progress and pitfalls;Ross;Cancer Epidemiol Biomarkers Prev,1999

5. Molecular biology of neuroblastoma;Maris;J Clin Oncol,1999

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chimeric single-chain variable fragment-human immunoglobulin G crystallizable fragment antibody against GD2 for neuroblastoma targeted immunotherapy;Exploration of Targeted Anti-tumor Therapy;2023-12-06

2. Neuroblastoma Molecular Risk-Stratification of DNA Copy Number and ALK Genotyping via Cell-Free Circulating Tumor DNA Profiling;Cancers;2021-07-05

3. Age at diagnosis as a prognostic factor in South African children with neuroblastoma;Pediatric Blood & Cancer;2021-01-23

4. Management of neuroblastoma in limited-resource settings;World Journal of Clinical Oncology;2020-08-24

5. Low DLG2 gene expression, a link between 11q-deleted and MYCN-amplified neuroblastoma, causes forced cell cycle progression, and predicts poor patient survival;Cell Communication and Signaling;2020-04-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3